Patents Represented by Attorney, Agent or Law Firm Jonathan Klein Evans
  • Recombinant anti-interleukin-9 antibodies
    Patent number: 7371383
    Abstract: The application describes neutralizing chimeric and humanized anti-human IL-9 antibodies, and the use thereof to identify neutralizing epitopes on human IL-9 and as medicaments to prevent and treat asthma, bronchial hyperresponsiveness, atopic allergy, and other related disorders. Particularly disclosed are recombinant antibodies derived from three murine anti-human IL-9 antibodies identified infra as MH9A3, MH9D1, and MH9L1.
    Type: Grant
    Filed: April 11, 2003
    Date of Patent: May 13, 2008
    Assignees: MedImmune, Inc., Ludwig Institute for Cancer Research
    Inventors: Jennifer Lynne Reed, William Dall'Acqua, Jacques Van Snick, Jean-Christophe Renauld, Francoise Cormont, Catherine Uyttenhove
  • Human cytomegalovirus DNA sequences
    Patent number: 6635477
    Abstract: Provided are novel Toledo and Towne human cytomegalovirus DNA sequences (HCMV) and proteins encoded thereby. The sequences are useful in methods and compositions for detecting HCMV infections and in immunogenic compositions for preventing HCMV infections.
    Type: Grant
    Filed: June 26, 2001
    Date of Patent: October 21, 2003
    Assignee: Med Immune Vaccines, Inc.
    Inventors: Richard Spaete, Tai-An Cha
  • Recombinant trytophan mutants of influenza
    Patent number: 6528064
    Abstract: Recombinant PB2 tryptophan variant influenza viruses, RNA, cDNA and vectors are provided. Also provided are immunogenic compositions containing the variant viruses, methods of producing such viruses and methods for the prophylactic treatment of influenza in humans.
    Type: Grant
    Filed: November 26, 2001
    Date of Patent: March 4, 2003
    Assignee: Med Immune Vaccines, Inc.
    Inventor: Neil T. Parkin